BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6746863)

  • 1. Radioiodine in the treatment of hereditary medullary carcinoma of the thyroid.
    Nieuwenhuijzen Kruseman AC; Bussemaker JK; Frölich M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):491-4. PubMed ID: 6746863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine in the treatment of medullary carcinoma of the thyroid.
    Saad MF; Guido JJ; Samaan NA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):124-8. PubMed ID: 6853671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma.
    Deftos LJ; Stein MF
    J Clin Endocrinol Metab; 1980 May; 50(5):967-8. PubMed ID: 7372781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
    Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine in the treatment of medullary carcinoma of the thyroid.
    Hellman DE; Kartchner M; Van Antwerp JD; Salmon SE; Patton DD; O'Mara R
    J Clin Endocrinol Metab; 1979 Mar; 48(3):451-5. PubMed ID: 429497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
    Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
    Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.
    Wiebe V; Schneider C; Franke HD
    Strahlentherapie; 1975 Jan; 149(1):55-9. PubMed ID: 1124555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
    Schraube P; Kimmig B; zum Winkel K
    Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
    Allan E; Owens SE; Waller ML
    Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of thyroid carcinoma with radioactive 131I.
    Paryani SB; Chobe RJ; Scott W; Wells J; Johnson D; Kuruvilla A; Schoeppel S; Deshmukh A; Miller R; Dajani L; Montgomery CT; Puestow E; Purcell J; Roura M; Sutton D; Mallett R; Peer J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):83-6. PubMed ID: 8823262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in serum thyroid peroxidase following radioiodine therapy of patients with differentiated thyroid carcinoma.
    Ozata M; Bayhan H; Bingöl N; Dündar S; Beyhan Z; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3634-8. PubMed ID: 8530612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.